ARCHIVES

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

This article is from The Cancer Letter archive.

Vol. 29 No. 15 | April 11, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Panel To Select Breast Committee Forom 130 Nominations; Bristol Plans Move To Princeton

December 6, 1991

Cancer Center To Get Recommended Funding, Restoration of 1990-91 Cuts, NCI Tells Directors

July 24, 1992

DCT Board Okays Concepts For New Trials In Imaging, Intraoperative RT

June 14, 1985

Nexavar Approved For Patients With Inoperable Liver Cancer

November 30, 2007

Eppley Contract Renewed; To Be Recompeted

January 20, 1978

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005